Not Lilly. Not Johnson & Johnson. This Stock Will Be the Biggest Healthcare Winner of 2026
Key PointsModerna’s shares soared following a major Phase 3 clinical trial win.
Key PointsModerna’s shares soared following a major Phase 3 clinical trial win.